J
Jeremy D. Richmon
Researcher at Massachusetts Eye and Ear Infirmary
Publications - 194
Citations - 6669
Jeremy D. Richmon is an academic researcher from Massachusetts Eye and Ear Infirmary. The author has contributed to research in topics: Transoral robotic surgery & Cancer. The author has an hindex of 42, co-authored 180 publications receiving 5389 citations. Previous affiliations of Jeremy D. Richmon include Harvard University & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma
Sofia Lyford-Pike,Shiwen Peng,Geoffrey D. Young,Janis M. Taube,William H. Westra,Belinda Akpeng,Tullia C. Bruno,Jeremy D. Richmon,Hao Wang,Justin A. Bishop,Lieping Chen,Charles G. Drake,Suzanne L. Topalian,Drew M. Pardoll,Sara I. Pai +14 more
TL;DR: The role of the PD-1:PD-L1 interaction in creating an "immune-privileged" site for initial viral infection and subsequent adaptive immune resistance once tumors are established is supported and a rationale for therapeutic blockade of this pathway is suggested in patients with HPV-HNSCC.
Journal ArticleDOI
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas.
Yuxuan Wang,Simeon Springer,Carolyn L. Mulvey,Natalie Silliman,Joy Schaefer,Mark Sausen,Nathan T. James,Eleni M. Rettig,Theresa Guo,Curtis R. Pickering,Justin A. Bishop,Christine H. Chung,Joseph A. Califano,Joseph A. Califano,David W. Eisele,Carole Fakhry,Carole Fakhry,Christine G. Gourin,Patrick K. Ha,Patrick K. Ha,Hyunseok Kang,Ana P. Kiess,Wayne M. Koch,Jeffrey N. Myers,Harry Quon,Jeremy D. Richmon,David Sidransky,Ralph P. Tufano,William H. Westra,Chetan Bettegowda,Luis A. Diaz,Nickolas Papadopoulos,Kenneth W. Kinzler,Bert Vogelstein,Nishant Agrawal +34 more
TL;DR: Analysis of DNA from saliva and plasma of 93 HNSCC patients found preliminary evidence suggesting that tumor DNA may be detectable in saliva before clinical evidence of tumor recurrence, which may be useful for patient monitoring if this result is confirmed in larger studies.
Journal ArticleDOI
Transoral endoscopic thyroidectomy vestibular approach (TOETVA): indications, techniques and results
Angkoon Anuwong,Thanyawat Sasanakietkul,Pornpeera Jitpratoom,Khwannara Ketwong,Hoon Yub Kim,Gianlorenzo Dionigi,Jeremy D. Richmon +6 more
TL;DR: TOETVA was shown to be safe and feasible with a reasonable surgical duration and minimal pain scores, and shows promise for those patients who are motivated to avoid a neck scar.
Journal ArticleDOI
The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer
Carole Fakhry,William H. Westra,Steven J. Wang,Annemieke van Zante,Yuehan Zhang,Eleni M. Rettig,Linda X. Yin,William R. Ryan,Patrick K. Ha,Alicia Wentz,Wayne M. Koch,Jeremy D. Richmon,David W. Eisele,Gypsyamber D'Souza +13 more
TL;DR: Survival differences were explored by the tumor HPV status among patients with OPSCCs by sex and race and patients with nonoropharyngeal (non‐OP) head and neck squamous cell cancers (HNSCCs).
Journal ArticleDOI
The "new" head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation.
TL;DR: Today’s caregiver must be prepared to appropriately evaluate, counsel, and treat patients with HPV-positive disease with the expectation that traditional treatment algorithms will evolve to maintain or improve current excellent cure rates while lessening treatment related side effects.